In a proposed pharmaceutical products liability class proceeding, the defendants moved for summary judgment before certification.
The plaintiffs alleged that a testosterone gel caused serious cardiovascular events, was improperly marketed for age-related low testosterone, and generated claims in negligence, failure to warn, unjust enrichment, waiver of tort, and pure economic loss.
The court held that although the evidence established an association and biological plausibility, it did not establish general causation on a balance of probabilities.
The court further held that an association may trigger a duty to warn, but any failure-to-warn claim still failed because causation was not proven.
The claims for unjust enrichment, waiver of tort, and pure economic loss also failed factually and legally, and the action was dismissed.